2019
DOI: 10.1142/s2661341719300015
|View full text |Cite
|
Sign up to set email alerts
|

Management of Psychosis in Neuropsychiatric Lupus

Abstract: Manifestations of neuropsychiatric systemic lupus erythematosus (NPSLE) are heterogeneous. Acute psychosis is an uncommon but well-recognized manifestation of NPSLE. With no specific biomarkers to date, the diagnosis of NPSLE relies on clinical acumen for circumstantial evidence and exclusion of important differential diagnoses. The attribution of psychosis to NPSLE is facilitated by the application attribution models. In particular, the American College of Rheumatology nomenclature, Systemic Lupus Internation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(10 citation statements)
references
References 61 publications
(81 reference statements)
1
9
0
Order By: Relevance
“…[ 12 ] Psychosis in SLE can occur either due to neuro-lupus or drugs used to treat it (e.g., glucocorticoid and chloroquine) or flare-up of premorbid psychiatric condition due to disease burden. [ 11 13 ] In the present case, steroid-induced psychosis was a close differential. Steroid may cause psychosis, usually with a higher dose of prednisolone (>40 mg/day), is dose dependent.…”
Section: Discussionmentioning
confidence: 55%
See 4 more Smart Citations
“…[ 12 ] Psychosis in SLE can occur either due to neuro-lupus or drugs used to treat it (e.g., glucocorticoid and chloroquine) or flare-up of premorbid psychiatric condition due to disease burden. [ 11 13 ] In the present case, steroid-induced psychosis was a close differential. Steroid may cause psychosis, usually with a higher dose of prednisolone (>40 mg/day), is dose dependent.…”
Section: Discussionmentioning
confidence: 55%
“…The standard treatment for NPSLE is pulse methylprednisolone therapy. [ 11 ] Our patient responded well with methylprednisolone, but had a recurrence in follow-up. Therefore, she was given monthly cyclophosphamide therapy that has been the best second-line agent having greater efficacy than methylprednisolone with comparable safety.…”
Section: Discussionmentioning
confidence: 81%
See 3 more Smart Citations